We are live on
!
Find out more
BFC
Blue Fin Capital Portfolio holdings
AUM
$692M
1-Year Est. Return
27.29%
This Fund
S&P 500
This Quarter
Est. Return
+8.08%
1 Year Est. Return
+27.29%
3 Year Est. Return
+125.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+590.83%
AUM
$202M
AUM Growth
+$14.7M
(+7.9%)
Cap. Flow
+$1.3M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
39.41%
Holding
126
New
2
Increased
39
Reduced
64
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookfield
BN
|
+$740K |
| 2 |
Amazon
AMZN
|
+$626K |
| 3 |
iShares Biotechnology ETF
IBB
|
+$588K |
| 4 |
Adobe
ADBE
|
+$388K |
| 5 |
PayPal
PYPL
|
+$337K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$286K |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$249K |
| 3 |
VGR
Vector Group Ltd.
VGR
|
+$222K |
| 4 |
Yum China
YUMC
|
+$213K |
| 5 |
Gilead Sciences
GILD
|
+$208K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.54% |
| 2 | Financials | 14.05% |
| 3 | Healthcare | 10.49% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Communication Services | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.52T
| $21.6M | 10.69% |
382,464
-1,924
| -0.5% | -$100K |
|
|
2
Amazon
AMZN
$2.99T
| $10.9M | 5.38% |
108,460
+6,660
| +7% | +$626K |
|
3
Microsoft
MSFT
$3.66T
| $7.77M | 3.85% |
67,911
+2,068
| +3% | +$224K |
|
4
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $7.39M | 3.66% |
85,518
+1,894
| +2% | +$163K |
|
5
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $7.17M | 3.55% |
192,993
-922
| -0.5% | -$34.6K |
|
6
iShares MSCI Emerging Markets ETF
EEM
$29.7B
| $5.37M | 2.66% |
125,212
+1,329
| +1% | +$57.4K |
|
7
Mastercard
MA
$500B
| $4.99M | 2.47% |
22,435
+215
| +1% | +$44.9K |
|
8
Visa
V
$690B
| $4.87M | 2.41% |
32,437
+444
| +1% | +$63.1K |
|
|
9
Alphabet (Google) Class A
GOOGL
$4.62T
| $4.8M | 2.38% |
79,580
-4,720
| -6% | -$286K |
|
10
Meta Platforms (Facebook)
META
$1.5T
| $4.75M | 2.35% |
28,898
+1,008
| +4% | +$182K |
|
11
iShares MSCI EAFE ETF
EFA
$79.3B
| $4.61M | 2.28% |
67,755
| – | – |
|
12
Berkshire Hathaway Class B
BRK.B
$1.12T
| $3.84M | 1.9% |
17,914
+61
| +0.3% | +$12.5K |
|
13
iShares Russell 3000 ETF
IWV
$20.3B
| $3.59M | 1.78% |
20,840
-100
| -0.5% | -$16.9K |
|
14
SPDR Gold Trust
GLD
$132B
| $3.27M | 1.62% |
29,003
+466
| +2% | +$53.5K |
|
|
RTN
15
DELISTED
Raytheon Company
RTN
| $2.97M | 1.47% |
14,389
-6
| -0% | -$1.19K |
|
16
iShares MSCI Emerging Markets Asia ETF
EEMA
$858M
| $2.88M | 1.43% |
42,445
-354
| -0.8% | -$24.2K |
|
17
UnitedHealth
UNH
$370B
| $2.84M | 1.41% |
10,689
+722
| +7% | +$188K |
|
18
Johnson & Johnson
JNJ
$614B
| $2.83M | 1.4% |
20,468
-31
| -0.2% | -$4.12K |
|
19
Invesco Senior Loan ETF
BKLN
$6.79B
| $2.72M | 1.35% |
117,231
+1,884
| +2% | +$43.4K |
|
20
ExxonMobil
XOM
$638B
| $2.65M | 1.31% |
31,138
-2,394
| -7% | -$196K |
|
21
JPMorgan Chase
JPM
$950B
| $2.5M | 1.24% |
22,175
+1,177
| +6% | +$134K |
|
22
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $2.47M | 1.22% |
22,871
+190
| +0.8% | +$20.4K |
|
23
Bank of America
BAC
$440B
| $2.27M | 1.12% |
76,872
-2,576
| -3% | -$78.5K |
|
24
Blackrock
BLK
$175B
| $2.23M | 1.11% |
4,739
+329
| +7% | +$160K |
|
25
Merck
MRK
$316B
| $2.15M | 1.06% |
31,681
-194
| -0.6% | -$12.4K |
|
Similar funds
CL
CPA
NMC
SSA
WC
CGIC
LCP
SAM
Blue Fin Capital's Q3 2018 Portfolio in Review
As of Q3 2018, Blue Fin Capital held 126 positions worth $202M, up 7.9% from $187M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Blue Fin Capital's Q3 2018 filing shows 2 new, 39 increased, 64 reduced and 5 closed positions. Its largest new stake was iShares Biotechnology ETF: 4,996 shares worth $609K. The largest sale was Alphabet (Google) Class A, an estimated $286K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Blue Fin Capital's largest Q3 2018 buy was iShares Biotechnology ETF: 4,996 shares worth $609K.
- Blue Fin Capital added most to Brookfield in Q3 2018, an estimated $740K increase.
- Blue Fin Capital's biggest Q3 2018 reduction was Alphabet (Google) Class A, cutting an estimated $286K.
- Blue Fin Capital fully exited State Street Energy Select Sector SPDR ETF in Q3 2018, selling an estimated $249K.
- Blue Fin Capital's ten largest holdings make up 39% of its $202M portfolio in Q3 2018.
- Blue Fin Capital opened 2 new positions and closed 5 in Q3 2018.
- Blue Fin Capital's portfolio value rose 7.9% quarter-over-quarter to $202M.
Based on Blue Fin Capital's 13F filing for Q3 2018, filed 9 Nov 2018.